anxiety depression News
-
Animal Emotional Behavior Tests for Anxiety and Depression Treatment
In today’s fast-paced and stressful society, the prevalence of anxiety and depression has become a significant concern. Emotion-related animal behavior tests aim to provide a good research tool for the study of emotion-associated diseases. Anxiety and depression affect millions of individuals worldwide, leading to a significant burden on public health and impacting overall quality of ...
By Protheragen
-
Antea Group Wellness Program Profiled by Employee Benefit News
Antea Group's employee wellness program takes a holistic approach, emcompassing the emotional, physical and financial aspects of well-being. The firm's recent efforts around mental health and stress management were recently featured in a piece in Employee Benefit News. The article spotlights the Learn to Live program of web-based cognitive behavioral therapy (or CBT) and the Vitality program, ...
-
Partnership researches emergency services recovery pathways
Partnership researches pathways to overcome depression and anxiety in emergency services personnel with PTSD UNSW Sydney and EML have earned an Australian Research Council grant to better understand and treat the links between PTSD, depression and anxiety in the NSW emergency services personnel. The ground-breaking three-year project aims to evaluate a NSW emergency services rehabilitation ...
-
Canaquest Launches Mentanine (Cannabidiol + IP Formula) in the US via www.canaqueststore.com, Supported by Western University Pre-Clinical Trials Targeting Anxiety, Depression and PTSD
Canaquest Medical Corp (OTC PINK:CANQF) (the “Company” or “CanaQuest“), an award-winning, Clinical Stage/Life-Sciences company focused on drug discovery and development of next-generation targeted therapeutics within the endocannabinoid system and specific brain receptors, today announced its US launch of all-natural Mentanine (cannabidiol “CBD” + IP, Omega-3s, ...
-
First findings from the Sixth European Working Conditions Survey released
Gender segregation remains persistent across the European labour market, younger workers experience greater work intensity and job insecurity, older workers report less access to training, female managers are on the increase while physical risks remain and there are significant differences in job quality across occupations. Violence in the workplace can take many different forms and is a major ...
-
Virtual Reality is being used in exciting ways to treat anxiety and depression
According to a Mashable article on a study of the efficacy of VR treatment for depression and anxiety, “This type of immersive therapy is a viable and potentially revolutionizing method to treat certain mental health conditions. A blend of VRET and well–established practices in mental health treatment can both augment and enhance other forms of therapy, the research suggests. For ...
By ni2o, Inc.
-
CanaQuest Launches Mentanine (R) (Cannabidiol + IP Formula) in the US via www.canaqueststore.com, Supported by Western University Pre-Clinical Trials Targeting Anxiety, Depression and PTSD
Canaquest Medical Corp (OTC Pink:CANQF) (the "Company" or "CanaQuest"), an award-winning, Clinical Stage/Life-Sciences company focused on drug discovery and development of next-generation targeted therapeutics within the endocannabinoid system and specific brain receptors, today announced its US launch of all-natural Mentanine® (cannabidiol "CBD" + IP, Omega-3s, DHA, EPA formula) in ...
-
ECC Awarded Pacific Business News` 2011 Healthiest Employer
Just two months after being recognized as a Top Workplace in the Bay Area by the San Jose Mercury News, ECC was named Pacific Business News' 2011 Healthiest Employer in Hawaii during an awards ceremony held at the Sheraton Waikiki. ECC placed first out of 10 companies competing for the title of the Healthiest Workplace for businesses with under 50 employees in Hawaii. Companies were evaluated in ...
-
Q&A with Dr. Carina Carnlöf, lead investigator of the RedHeart study
In the recently published RedHeart Study the Coala Heart Monitor was used to remotely monitor 821 women with palpitation issues for 60 days. Over 200,000 individual ECG strips were analyzed. The direct ECG response of the Coala Heart Monitor contributed to reduced levels of anxiety, depression and symptoms of palpitations. The direct ECG response of the Coala also led to an increased quality of ...
-
CanaQuest Files International Mentanine(R) Patent, a Scientific CBD Formulation for Mental Health
Canaquest Medical Corp (OTC PINK:CANQF) (the “Company” or “CanaQuest“), an award-winning Life Science/Pharmaceutical company developing formulations combining cannabinoid molecules with pharmaceutical-grade botanical compounds, today announced the filing of its International Patent, trade named Mentanine, which has demonstrated at least 10-times (10X) the efficacy compared ...
-
RedHeart study proves improved health-related quality of life (HRQOL) using the Coala groundbreaking digital technology
Coala Life today announced the results of the RedHeart Study where the Coala Heart Monitor (“Coala”) was used to evaluate 821 women with palpitation symptoms over 60 days. Goals were to determine to what degree direct feedback of the underlying heart rhythm, such as provided by the Coala through its instant ECG analysis could help to reduce symptoms caused by palpitations and increase ...
-
CanaQuest Achieves Statistically Significant Reduction of Seizures for Epilepsy Compared to Standard CBD
CANAQUEST MEDICAL CORP (OTC PINK:CANQF) (the "Company" or "CanaQuest"), a clinical-stage life sciences company focused on drug discovery and development of next-generation targeted cannabinoid therapeutics for the central nervous system (CNS), today announced Statistically Significant efficacy results from the Clinical Dose & Efficacy Study ("Study") conducted by Dr. W McIntyre Burnham, ...
-
Lt. Governor Rutherford Leads Maryland Delegation to MEDICA 2021 Trade Show in Germany
Medical forum attracts thousands of exhibitors from more than 50 countries across the globe BALTIMORE, MD (November 16, 2021) — Lt. Governor Boyd K. Rutherford is leading a delegation of 10 Maryland companies this week to MEDICA 2021, the world’s largest medical trade show in Dusseldorf, Germany, which typically attracts more than 120,000 attendees from around the world. This is the ...
-
CanaQuest Signs Medicinal Cannabis Education Partnership with the Canadian Cannabis Dispute Resolution Centre
Canaquest Medical Corp (OTC Markets: “CANQF”) (the “Company” or “CanaQuest”), a Life Science/Pharmaceutical Company developing health products utilizing cannabinoid molecules and other botanical compounds (pharmaceutical grade), is pleased to announce its new partnership with the Canadian Cannabis Dispute Resolution Centre (“CCDRC”), a national ...
-
Fundamental Research Corp Initiates Coverage on CanaQuest (CANQF) with Buy Rating and US$0.78 Fair Value Estimate
Canaquest Medical Corp (OTC PINK:CANQF) (the “Company” or “CanaQuest“), a Life Science/Pharmaceutical Company developing health products utilizing cannabinoid molecules and other botanical compounds (pharmaceutical grade), today announced that Fundamental Research Corp (“FRC”), one of the world’s largest independent research houses, has launched coverage ...
-
CanaQuest Medical Corp Appoints Investor Relations and PR Veteran Rob Rinderman as its New Director of Communications
Canaquest Medical Corp (OTC PINK:CANQF) (the “Company” or “CanaQuest“), an award-winning Life Science/Pharmaceutical company developing health and wellness products combining cannabinoid molecules with pharmaceutical-grade botanical compounds, today announced that Rob Rinderman has joined CanaQuest as its new Director of Communications. Mr. Rinderman will focus on managing ...
-
CANAQUEST Announces Award of European Cannabinoid Patent
We believe we can provide a safer alternative to other THC products providing the benefits without the negative psychiatric side effects. Pre-clinical trials have demonstrated the reversal of depression-like and schizophrenia-related symptoms, blockage of memory impairment, hyperactive activity, and gene vulnerability. CanaQuest Medical Corp ("CanaQuest" or the "Company") (OTC:CANQF), a ...
-
Clinical study authorised in Sweden for the investigation of CDNF and Renishaw drug delivery system in Parkinson`s patients
The Medicines Agency of Sweden, MPA, has authorised Herantis Pharma Plc and Renishaw plc's randomised, placebo-controlled Phase 1-2 clinical study, for the investigation of Cerebral Dopamine Neurotrophic Factor (CDNF) and Renishaw's chronic drug delivery system, in Parkinson's patients. The first study site to start patient recruitment will be the Karolinska University Hospital in Stockholm, ...
By Renishaw plc
-
Neopharmed Gentili acquires Lormetazepam product portfolio to strengthen its neurology division
Neopharmed Gentili acquires rights in Italy and Japan to the historical brands Minias® and Noctamid® (Italy) and Evamyl® (Japan). The transaction allows Neopharmed Gentili to strengthen its portfolio in the neuro-psychiatric area with high value-added drugs for the treatment of insomnia. Neopharmed Gentili, an Italian pharmaceutical company controlled by Ardian in partnership ...
-
Gulf Study Gears Up for Second Round of Health Exams
Researchers at the National Institutes of Health, leading the largest health study ever conducted on the potential health effects of an oil spill, are encouraging participants to stay involved in this long-term project. All participants are being contacted for telephone interviews to update their health status. Those living within 60 miles of Mobile, Ala., and New Orleans also will be invited to ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you